Open-Label, Balanced, Randomized,Two-Treatment, Two-Sequence, Two-Period, Single-Dose, Crossover Oral Bioequivalence Study Of Ibandronate Sodium 150 mg Tablets Of Dr. Reddy's Laboratories Limited, India and BONIVA 150 mg (Ibandronate Sodium) Tablets Of Roche Laboratories Inc., USA In Healthy, Adult, Human Subjects Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2012
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Cancer metastases; Postmenopausal osteoporosis
- Focus Pharmacokinetics
- 02 Jul 2012 New trial record